CA2927146A1 - Compositions et methodes de traitement et d'inhibition d'infections virales - Google Patents

Compositions et methodes de traitement et d'inhibition d'infections virales Download PDF

Info

Publication number
CA2927146A1
CA2927146A1 CA2927146A CA2927146A CA2927146A1 CA 2927146 A1 CA2927146 A1 CA 2927146A1 CA 2927146 A CA2927146 A CA 2927146A CA 2927146 A CA2927146 A CA 2927146A CA 2927146 A1 CA2927146 A1 CA 2927146A1
Authority
CA
Canada
Prior art keywords
warts
pharmaceutically acceptable
treatment
chloroquine
amodiaquine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2927146A
Other languages
English (en)
Inventor
Justice E. OBI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRACELAND BIOTECHNOLOGY CATALYST LLC
Original Assignee
GRACELAND BIOTECHNOLOGY Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/540,749 external-priority patent/US20140011837A1/en
Priority claimed from US13/687,273 external-priority patent/US20140011838A1/en
Priority claimed from US13/932,445 external-priority patent/US20140011839A1/en
Application filed by GRACELAND BIOTECHNOLOGY Inc filed Critical GRACELAND BIOTECHNOLOGY Inc
Publication of CA2927146A1 publication Critical patent/CA2927146A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
CA2927146A 2012-07-03 2013-07-02 Compositions et methodes de traitement et d'inhibition d'infections virales Abandoned CA2927146A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13/540,749 2012-07-03
US13/540,749 US20140011837A1 (en) 2012-07-03 2012-07-03 Compositions and methods for treating warts associated with viral infections
US13/687,273 2012-11-28
US13/687,273 US20140011838A1 (en) 2012-07-03 2012-11-28 Compositions and methods for treating warts associated with viral infections
US13/932,445 US20140011839A1 (en) 2012-07-03 2013-07-01 Compositions and methods for treating and inhibiting viral infections
US13/932,445 2013-07-01
PCT/US2013/049046 WO2014008248A2 (fr) 2012-07-03 2013-07-02 Compositions et méthodes de traitement et d'inhibition d'infections virales

Publications (1)

Publication Number Publication Date
CA2927146A1 true CA2927146A1 (fr) 2014-01-09

Family

ID=49882589

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2927146A Abandoned CA2927146A1 (fr) 2012-07-03 2013-07-02 Compositions et methodes de traitement et d'inhibition d'infections virales

Country Status (4)

Country Link
EP (1) EP2869821A4 (fr)
CN (1) CN104703601A (fr)
CA (1) CA2927146A1 (fr)
WO (1) WO2014008248A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2544153B1 (es) 2014-02-24 2016-06-06 Ntd Labs, S.L. Uso de un hidrolizado de caseína como agente antiviral
CN104352495A (zh) * 2014-11-15 2015-02-18 广州凯普生物科技有限公司 一种治疗疣类疾病的药物
WO2018191642A1 (fr) * 2017-04-13 2018-10-18 Texas Biomedical Research Institute Nouveaux analogues d'amodiaquine et leurs procédés d'utilisation
WO2020033329A1 (fr) * 2018-08-06 2020-02-13 Nielsen Biosciences, Inc. Traitement des verrues
CN109288816B (zh) * 2018-12-04 2019-11-22 广州凯普医药科技有限公司 一种氯喹凝胶及其制备方法和应用
CN110917196B (zh) * 2020-02-05 2020-06-05 广州康健医学科技有限公司 一种氯喹抑菌消毒液及其应用
CN112089841A (zh) * 2020-04-05 2020-12-18 徐静 用于治疗上皮组织病毒感染所致疾病的药物组合物
CN114848642A (zh) * 2022-07-07 2022-08-05 广州康健医学科技有限公司 磷酸氯喹在制备防治高危型hpv感染及宫颈癌前病变与宫颈癌的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00010068A (es) * 1998-04-14 2002-08-06 Jomaa Hassan Uso de compuestos organofosforicos para el tratamiento terapeutico y preventivo de infecciones.
WO2009023059A2 (fr) * 2007-06-01 2009-02-19 The Trustees Of Princeton University Traitement d'infections virales par modulation de voies métaboliques de cellules hôtes

Also Published As

Publication number Publication date
EP2869821A2 (fr) 2015-05-13
CN104703601A (zh) 2015-06-10
EP2869821A4 (fr) 2016-04-06
WO2014008248A2 (fr) 2014-01-09
WO2014008248A3 (fr) 2014-02-27

Similar Documents

Publication Publication Date Title
CA2927146A1 (fr) Compositions et methodes de traitement et d'inhibition d'infections virales
JP6307202B1 (ja) 新規ヨードフォア組成物および使用方法
NZ305095A (en) Water-based topical cream containing nitroglycerin, use in treating sexual dysfunction
RU2578979C2 (ru) Композиция и способ лечения болезненных состояний кожи
US6407125B1 (en) Pharmacological agent and method of treatment
JPH06100446A (ja) （Ｓ）−α−フルオロメチル−ヒスチジン及びそのエステルを使用するぜん息の治療方法
US20060074063A1 (en) Pharmacological agent and method of treatment
US20140011838A1 (en) Compositions and methods for treating warts associated with viral infections
US20140011839A1 (en) Compositions and methods for treating and inhibiting viral infections
AU781066B2 (en) Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
US20170296530A1 (en) Compositions and Methods for Treating and Inhibiting Viral Infections
US9144612B2 (en) Dermatological compositions containing an association of peroxide lipids and zinc, and uses thereof in particular in the treatment of labial and/or genital herpes
US20140011837A1 (en) Compositions and methods for treating warts associated with viral infections
US9770448B1 (en) Compositions and methods for treatment of Bowen's disease and related diseases
AU2010263478A1 (en) Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
de Bengoa Vallejo et al. Application of cantharidin and podophyllotoxin for the treatment of plantar warts
EP3687541A1 (fr) Compositions et méthodes pour le traitement de la maladie de bowen et de maladies associées
JP2007525493A (ja) いぼをテルル化合物により治療するための治療法および医薬組成物
Falkland Disease management: The diagnosis and management of warts
JPS6327432A (ja) 高増殖性上皮疾患の治療のための局部的なメトトレキセ−ト調製物およびそれを用いた高増殖性上皮疾患の治療方法
Adıyaman et al. Verruca vulgaris and acupuncture: A case report and literature review
KR101671484B1 (ko) 오셀타미비르(Oseltamivir)를 포함하는 인유두종 바이러스 치료용 약학적 조성물
JP2006508071A (ja) ホルモン置換療法のための１７β‐エストラジオール／レボノルゲストレル経皮的パッチ
EP3241555A1 (fr) Utilisation d'analogues de l'ion pyrophosphate pour le traitement de l'infection par vph
RU2595832C1 (ru) Способ достижения длительной клинической ремиссии хронической впч-инфекции, проявляющейся остроконечными кондиломами аногенитальной области

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20151223

FZDE Dead

Effective date: 20180704